Gene-Disorder Association · Article
Gene
APOEApolipoprotein E
×
First reported
1994
Supporting publications
60
Manually curatedApproved treatment annotated
Association Review
In brief
The association between APOE (Apolipoprotein E) and Dementia is reported, with clinical genetic testing available.
Sources
1
Clinical variants
0
Symptoms
12
Compounds
1
Trials
42of 271 via APOE compounds
Publications
60
01
At a glance
Association overview
A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.
Request access
02
Provenance
Evidence and sources
1 source
Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.
Request access
1 source summary
A gene summary alongside the source descriptions it was distilled from.
Request access
7 database identifiers
The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).
Request access
05
Population genetics
GWAS signals
5 GWAS phenotypes
Gene-associated GWAS phenotypes matching the disorder, with best SNP, score, risk-allele frequency and effect size.
Request access
06
Interventions
Therapeutics
1 compound or drug
Gene-targeting drugs and associated compounds, with class, approval status, mechanism, indications and trials.
Request access
07
Human studies
Clinical trials
271 clinical trials
Clinical trials reached through the pair’s compounds, keeping disorder-targeting trials separate from other indications.
Request access
60 publications
Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.
Request access
09
Provenance
References & sources
14 references
Every source and publication cited across this dossier, as one numbered reference list.
Request access